IMGO

NASDAQ

Imago BioSciences Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2021

News25/Ratings6

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Latest news

25 items

276dPR
Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies
Omega Funds, a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced the closing of its eighth fund with $647 million in capital commitments. The new fund, Omega Fund VIII, L.P. ("Fund VIII"), was oversubscribed, exceeding its target of $600 million, garnering strong support from both new and existing limited partners. With Fund VIII, the firm will continue to execute its strategy of creating and investing in innovative life sciences companies in the U.S. and Europe that target severe, unmet medical needs. Since its inception in 2004, Omega Funds has raised $2.5 billion to invest in exceptional entrepreneurs developing
1164d13D/G
SEC Form SC 13G/A filed by Imago BioSciences Inc. (Amendment)
SC 13G/A - Imago BioSciences, Inc. (0001623715) (Subject)
1177d13D/G
SEC Form SC 13G/A filed by Imago BioSciences Inc. (Amendment)
SC 13G/A - Imago BioSciences, Inc. (0001623715) (Subject)
1183d13D/G
SEC Form SC 13G/A filed by Imago BioSciences Inc. (Amendment)
SC 13G/A - Imago BioSciences, Inc. (0001623715) (Subject)
1186dSEC
SEC Form 15-12G filed by Imago BioSciences Inc.
15-12G - Imago BioSciences, Inc. (0001623715) (Filer)
1189d13D/G
SEC Form SC 13G/A filed by Imago BioSciences Inc. (Amendment)
SC 13G/A - Imago BioSciences, Inc. (0001623715) (Subject)
1192dSEC
SEC Form EFFECT filed by Imago BioSciences Inc.
EFFECT - Imago BioSciences, Inc. (0001623715) (Filer)
1197d13D/G
SEC Form SC 13D/A filed by Imago BioSciences Inc. (Amendment)
SC 13D/A - Imago BioSciences, Inc. (0001623715) (Subject)
1198dINSIDER
SEC Form 4 filed by Keating Laurie
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4: Tapper Amy E. closing all direct ownership in the company
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4 filed by Kariuki Enoch
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4: Rienhoff Hugh Jr closing all direct ownership in the company
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4 filed by Eichorn Laura G.
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4: Henner Dennis closing all direct ownership in the company
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4: Arenberg Michael closing all direct ownership in the company
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4 filed by Chaya Moghrabi Dina
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4: Chiang Hsiangyi closing all direct ownership in the company
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4: Peppe Jennifer closing all direct ownership in the company
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dINSIDER
SEC Form 4: Baltera Robert Jr. closing all direct ownership in the company
4 - Imago BioSciences, Inc. (0001623715) (Issuer)
1198dSEC
SEC Form 25-NSE filed by Imago BioSciences Inc.
25-NSE - Imago BioSciences, Inc. (0001623715) (Subject)
1198dSEC
SEC Form S-8 POS filed by Imago BioSciences Inc.
S-8 POS - Imago BioSciences, Inc. (0001623715) (Filer)
1198dSEC
SEC Form S-8 POS filed by Imago BioSciences Inc.
S-8 POS - Imago BioSciences, Inc. (0001623715) (Filer)
1198dSEC
SEC Form POS AM filed by Imago BioSciences Inc.
POS AM - Imago BioSciences, Inc. (0001623715) (Filer)
1198dSEC
Imago BioSciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Financial Statements and Exhibits
8-K - Imago BioSciences, Inc. (0001623715) (Filer)
1198dSEC
SEC Form SC 14D9/A filed by Imago BioSciences Inc. (Amendment)
SC 14D9/A - Imago BioSciences, Inc. (0001623715) (Subject)